X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (48) 48
rats (30) 30
mice (29) 29
male (28) 28
guinea pigs (25) 25
chemistry, medicinal (21) 21
article (19) 19
structure-activity relationship (19) 19
biochemistry & molecular biology (18) 18
oligopeptides - pharmacology (18) 18
receptors, opioid, mu - agonists (18) 18
index medicus (16) 16
in vitro techniques (14) 14
pc12 cells (14) 14
receptors, opioid, delta - antagonists & inhibitors (14) 14
brain - metabolism (13) 13
dmt-tic pharmacophore (13) 13
humans (13) 13
vas deferens - drug effects (13) 13
receptors, opioid, delta - agonists (12) 12
ileum - drug effects (11) 11
pharmacology & pharmacy (11) 11
vas deferens - physiology (11) 11
antinociception (10) 10
dopal (10) 10
dopamine (10) 10
dose-response relationship, drug (10) 10
muscle, smooth - drug effects (10) 10
neurosciences (10) 10
potent (10) 10
radioligand assay (10) 10
analogs (9) 9
ileum - physiology (9) 9
ligands (9) 9
muscle contraction - drug effects (9) 9
muscle, smooth - physiology (9) 9
oligopeptides - chemical synthesis (9) 9
3,4-dihydroxyphenylacetaldehyde (8) 8
3,4-dihydroxyphenylacetic acid - analogs & derivatives (8) 8
3,4-dihydroxyphenylacetic acid - metabolism (8) 8
analgesia (8) 8
binding, competitive (8) 8
dipeptides - chemistry (8) 8
dopamine - metabolism (8) 8
mediated analgesia (8) 8
oligopeptides - chemistry (8) 8
parkinson's disease (8) 8
peptides (8) 8
receptors, opioid, mu - antagonists & inhibitors (8) 8
analgesics - pharmacology (7) 7
dipeptides - pharmacology (7) 7
dmt (7) 7
injections, intraventricular (7) 7
rats, sprague-dawley (7) 7
stereoisomerism (7) 7
synaptosomes - metabolism (7) 7
tyrosine - analogs & derivatives (7) 7
agonist (6) 6
cell line (6) 6
chemistry, organic (6) 6
dipeptides - chemical synthesis (6) 6
metabolites (6) 6
parkinsons-disease (6) 6
receptors, opioid, mu - metabolism (6) 6
selectivity (6) 6
tetrahydroisoquinolines - chemistry (6) 6
agonists (5) 5
aldehyde dehydrogenase (5) 5
alpha-synuclein (5) 5
antagonist (5) 5
cell biology (5) 5
electric stimulation (5) 5
high-affinity (5) 5
inhibition (5) 5
monoamine oxidase (5) 5
morphine (5) 5
muscle, smooth - innervation (5) 5
opiate receptor (5) 5
oxidative stress (5) 5
phenols (5) 5
receptors, opioid, delta - metabolism (5) 5
spinal (5) 5
tetrahydroisoquinolines - chemical synthesis (5) 5
tetrahydroisoquinolines - pharmacology (5) 5
toxicology (5) 5
tyrosine - chemical synthesis (5) 5
tyrosine - pharmacology (5) 5
aldehydes (4) 4
alpha-synuclein - metabolism (4) 4
analgesics - chemical synthesis (4) 4
analgesics, opioid - chemistry (4) 4
analgesics, opioid - pharmacology (4) 4
anti-opioid (4) 4
biotechnology & applied microbiology (4) 4
chemistry, applied (4) 4
derivatives (4) 4
endogenous agonist (4) 4
endomorphin (4) 4
food science & technology (4) 4
injections, subcutaneous (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 12/2012, Volume 123, Issue 6, pp. 932 - 943
Journal Article
Journal Article
Clinical Autonomic Research, ISSN 0959-9851, 4/2018, Volume 28, Issue 2, pp. 223 - 230
Lewy body forms of primary chronic autonomic failure (CAF) such as incidental Lewy body disease (ILBD), Parkinson’s disease (PD), and pure autonomic failure... 
Neurology | Medicine & Public Health | Gastroenterology | Diabetes | Ophthalmology | Cardiology | Synuclein | Immunofluorescence | Endocrinology | Sympathetic | Autonomic | Lewy | REDUCED VESICULAR STORAGE | NERVE | NEURODEGENERATION | LEWY BODY DISEASE | DOPAMINE METABOLITE 3,4-DIHYDROXYPHENYLACETALDEHYDE | NEUROSCIENCES | CLINICAL NEUROLOGY | CARDIAC DENERVATION | DEGENERATION | MULTIPLE SYSTEM ATROPHY | BODIES | PARKINSONS-DISEASE | Tyrosine 3-Monooxygenase - metabolism | Parkinson Disease - pathology | Pure Autonomic Failure - pathology | Humans | Lewy Body Disease - pathology | Pure Autonomic Failure - metabolism | Ganglia, Sympathetic - metabolism | Tyrosine 3-Monooxygenase - analysis | Ganglia, Sympathetic - chemistry | Lewy Body Disease - metabolism | alpha-Synuclein - analysis | Ganglia, Sympathetic - pathology | Parkinson Disease - metabolism | Chronic Disease | alpha-Synuclein - metabolism | Tyrosine | Phenols | Nervous system diseases | Hydroxylases | Neurons | Dementia | Parkinson's disease | Neurodegenerative diseases | Platelet-activating factor | Brain stem | Lewy body disease | Hydroxylase | Cytotoxicity | Sympathetic ganglia | Tyrosine 3-monooxygenase | Ganglia | Lewy bodies | Atrophy | Tau protein | Autonomic nervous system | Autopsy | Sympathetic nerves | Dementia disorders | Norepinephrine | Heart diseases | Movement disorders | Denervation
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2018, Volume 366, Issue 1, pp. 113 - 124
The catecholaldehyde hypothesis posits that 3,4-dihydroxyphe-nylacetaldehyde (DOPAL), an obligate intermediary metabolite of dopamine, is an autotoxin that... 
VESICULAR STORAGE | MULTIPLE SYSTEM ATROPHY | TOXIC DOPAMINE METABOLITE | DOPAL | ALPHA-SYNUCLEIN PHOSPHORYLATION | PARKINSONS-DISEASE PATHOGENESIS | ALDEHYDE DEHYDROGENASE-ACTIVITY | IN-VIVO | NEURODEGENERATION | PHARMACOLOGY & PHARMACY | PC12 CELLS | Toxicology
Journal Article
Journal of neurochemistry, ISSN 0022-3042, 4/2015, Volume 133, Issue 1, pp. 14 - 25
Repeated systemic administration of the mitochondrial complex I inhibitor rotenone produces a rodent model of Parkinson disease (PD). Mechanisms of relatively... 
Parkinson disease | DOPAL | Dihydroxyphenylacetaldehyde | Aldehyde dehydrogenase | Vesicular monoamine transporter | Rotenone
Journal Article
Chemical Research in Toxicology, ISSN 0893-228X, 08/2014, Volume 27, Issue 8, pp. 1359 - 1361
The dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) is detoxified mainly by aldehyde dehydrogenase (ALDH). We find that the fungicide benomyl... 
Rapid Report
Journal Article
Journal Article